Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 200 MG
SDP

Supplier:  Medchemexpress LLC HY15067200MG

Encompass_Preferred

DNQX (FG 9041) is a quinoxaline derivative and a selective, potent competitive non-NMDA glutamate receptor antagonist. It is characterized by its activity against various glutamate receptors.

  • Selective, potent competitive non-NMDA glutamate receptor antagonist
  • Targets AMPA receptors with an IC50 of 0.5 μM
  • Targets kainate receptors with an IC50 of 2 μM
  • Targets NMDA receptors with an IC50 of 40 μM
  • Selectively depolarizes thalamic reticular nucleus (TRN) neurons in vitro
  • Diminishes phencyclidine (PCP) induced hsp70 induction in vivo

Catalog No. 50-003-75118


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.